Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CT › New Britain › NPI 1437252806
Lab

Starling Physicians, PLLC

Starling Physicians, PLLC was paid $4.36M by Medicaid between Jan 2018 and Dec 2024, across 78 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 11% of everything it billed.

33Billing provider infoSTARLING PHYSICIANS, PLLC
NEW BRITAIN, CT 06052
33aNPI1437252806assigned 09/07/2006
28Total paid$4.36M
24GClaims430,053
24DCodes billed78
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Connecticut

Rank by total paid#7 of 27
Median peer was paid$561K
This provider vs. median7.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201841,999$346K
201943,348$407K
202043,595$414K
202160,688$739K
202268,121$975K
2023103,025$783K
2024incomplete69,277$697K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 11% 16,936 14,667 $481K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 11% 16,835 14,568 $478K
80050 General health panel 8.7% 13,097 11,292 $380K
81513 7.0% 2,961 2,275 $304K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 5.9% 12,668 11,122 $259K
80061 Lipid panel 5.6% 28,210 24,533 $246K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4.4% 37,504 30,906 $191K
80053 Comprehensive metabolic panel 3.6% 26,955 21,548 $156K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 3.6% 1,159 1,048 $155K
84443 Thyroid stimulating hormone (TSH) 3.3% 14,265 12,374 $143K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2.9% 5,197 4,282 $126K
83036 Hemoglobin; glycosylated (A1C) 2.9% 20,577 17,728 $125K
66 more codes
36415 Collection of venous blood by venipuncture 2.4% 66,583 $107K
82607 2.0% 9,152 $89K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.9% 4,787 $84K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.8% 1,083 $79K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.8% 3,174 $78K
87481 1.7% 3,034 $74K
82728 1.6% 7,721 $71K
82746 1.4% 6,111 $61K
85027 1.2% 12,062 $53K
88305 Level IV - Surgical pathology, gross and microscopic examination 1.2% 3,352 $50K
84439 <1% 6,944 $43K
87340 <1% 4,967 $41K
83550 <1% 5,993 $33K
84153 <1% 2,792 $33K
80048 Basic metabolic panel (calcium, ionized) <1% 7,325 $32K
86803 <1% 2,969 $31K
84702 <1% 3,319 $31K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,086 $26K
82274 <1% 2,242 $25K
86762 <1% 1,915 $22K
81001 <1% 10,428 $22K
86592 <1% 5,035 $17K
86140 <1% 4,618 $15K
81003 <1% 9,515 $15K
80076 <1% 2,594 $14K
83540 <1% 3,526 $14K
83970 <1% 857 $11K
85651 <1% 4,806 $11K
86780 <1% 1,072 $11K
87625 <1% 470 $11K
82570 <1% 4,314 $10K
82043 <1% 3,949 $10K
82950 <1% 2,398 $9K
83735 <1% 2,383 $9K
85610 <1% 3,751 $9K
80069 <1% 1,552 $7K
82670 <1% 310 $7K
82947 <1% 1,821 $6K
83615 <1% 1,445 $5K
83001 <1% 332 $5K
88312 <1% 474 $5K
84146 <1% 298 $4K
84450 <1% 1,787 $4K
84550 <1% 2,402 $4K
82565 <1% 936 $3K
84100 <1% 911 $2K
86431 <1% 538 $2K
85045 <1% 538 $1K
84156 <1% 461 $1K
84520 <1% 494 $776.86
88304 <1% 79 $758.76
82951 <1% 85 $725.11
84460 <1% 1,804 $493.61
85730 <1% 120 $483.26
82550 <1% 152 $467.13
82465 <1% 102 $390.10
85018 <1% 147 $289.48
82952 <1% 98 $266.22
85014 <1% 104 $205.50
83721 <1% 25 $202.25
85652 <1% 85 $182.86
85007 <1% 60 $175.92
84436 <1% 13 $72.16
81015 <1% 15 $34.80
G0103 Prostate cancer screening; prostate specific antigen test (psa) 0% 154 $0.00
93000 0% 20 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEBENGER, JEFFREY (CEO)
Same official

Other billing entities under LEBENGER, JEFFREY

Full network →
ProviderLocationPaid
Starling Physicians, PLLCRocky Hill, CT$38.11M
Summit Medical Group PAWoodland Park, NJ$45K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.